Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of the Combination Carboplatin Plus Celecoxib in Heavily Pre-treated Recurrent Ovarian Cancer Patients

NCT01124435 is registered in ClinicalTrials.gov with Catholic University of the Sacred Heart as lead sponsor.

NCT NCT01124435
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01124435 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of the Combination Carboplatin Plus Celecoxib in Heavily Pre-treated Recurrent Ovarian Cancer Patients
Lead sponsor
Catholic University of the Sacred Heart
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2003
Completion date
December 31, 2008
Enrollment
45 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian neoplasms